Pfizer Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar '26 Mar 29, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 28, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 30, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 29, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Oct '23 Oct 1, 2023	Jul '23 Jul 2, 2023	Apr '23 Apr 2, 2023	Dec '22 Dec 31, 2022	Oct '22 Oct 2, 2022	Jul '22 Jul 3, 2022	Apr '22 Apr 3, 2022	Dec '21 Dec 31, 2021	Oct '21 Oct 3, 2021	Jul '21 Jul 4, 2021
Cash & Equivalents	1,703	1,142	1,343	1,638	1,430	1,043	1,092	1,052	719	2,853	3,148	2,632	2,166	416	1,298	1,780	2,470	1,944	1,966	2,372
Short-Term Investments	11,372	12,454	13,641	11,611	15,887	19,434	8,860	6,048	11,209	9,837	41,033	42,153	17,806	22,316	34,825	31,524	21,427	29,125	27,730	19,328
Cash & Short-Term Investments	13,075	13,596	14,984	13,249	17,317	20,477	9,952	7,100	11,928	12,690	44,181	44,785	19,972	22,732	36,123	33,304	23,897	31,069	29,696	21,700
Cash Growth	-24.50%	-33.60%	50.56%	86.61%	45.18%	61.36%	-77.47%	-84.15%	-40.28%	-44.18%	22.31%	34.47%	-16.43%	-26.83%	21.64%	53.47%	74.85%	154.19%	35.52%	-4.80%
Accounts Receivable	12,585	11,874	14,260	12,078	11,845	11,463	14,451	11,393	10,989	11,566	11,086	10,231	12,305	10,952	16,076	15,155	13,225	11,479	11,897	10,587
Inventory	10,667	10,654	11,468	11,669	10,852	10,851	11,721	11,447	10,892	10,189	10,204	10,310	9,541	8,981	9,513	10,454	9,979	9,059	8,640	8,948
Other Current Assets	6,496	6,775	6,213	6,706	5,847	7,567	7,098	7,884	8,605	8,889	8,541	8,022	8,260	8,594	8,693	8,553	7,319	8,086	7,667	7,579
Total Current Assets	42,822	42,898	46,924	43,703	45,861	50,358	43,223	37,825	42,415	43,333	74,012	73,347	50,078	51,259	70,403	67,466	54,420	59,693	57,900	48,814
Net Property, Plant & Equipment	19,402	19,317	18,880	18,776	18,347	18,393	18,541	18,957	18,803	18,940	17,862	17,488	17,052	16,274	15,441	15,244	15,109	14,882	14,436	14,224
Other Intangible Assets	52,559	53,731	51,324	52,702	53,976	55,411	59,986	61,240	62,829	64,900	40,224	41,406	42,002	43,370	28,151	29,065	29,816	25,146	26,306	27,323
Goodwill	71,409	71,264	69,101	68,997	68,444	68,527	68,570	68,445	69,297	67,783	51,527	51,572	51,476	51,375	49,441	49,891	50,211	49,208	49,489	49,867
Long-Term Investments	1,626	1,621	2,137	2,120	2,013	2,228	10,762	11,148	11,613	15,368	14,239	15,066	14,743	15,069	13,888	18,962	20,737	21,526	21,597	20,942
Other Long-Term Assets	19,799	19,330	20,365	19,798	19,387	18,479	18,395	18,577	16,139	16,177	17,158	21,289	20,267	19,856	18,026	14,661	13,547	11,020	9,460	8,750
Total Assets	207,618	208,160	208,731	206,095	208,028	213,396	219,476	216,193	221,095	226,501	215,021	220,168	195,617	197,205	195,350	195,290	183,841	181,476	179,188	169,920
Accounts Payable	4,506	5,240	5,024	5,166	5,240	5,633	5,314	5,106	5,591	6,710	5,338	6,081	6,123	6,809	6,267	6,208	5,506	5,578	4,698	4,327
Accrued Expenses	2,715	3,610	3,036	2,447	2,607	3,838	3,383	2,566	2,192	2,776	2,372	1,972	2,277	3,407	2,852	1,997	2,249	3,332	2,571	2,015
Short-Term Debt	3,890	3,154	4,303	4,295	4,470	6,946	9,699	11,944	8,232	10,350	2,548	3,985	4,188	2,945	4,040	5,990	645	2,241	3,629	3,888
Unearned Revenue	-	784	924	1,123	1,012	1,511	2,020	2,528	2,502	2,700	2,204	1,286	1,750	2,520	6,191	3,804	3,108	3,067	3,529	4,291
Other Current Liabilities	23,238	24,196	23,308	24,695	23,121	25,067	22,794	21,674	21,980	25,258	18,674	21,322	22,224	26,458	24,963	29,411	27,760	28,454	27,377	21,143
Total Current Liabilities	34,348	36,984	36,596	37,726	36,452	42,995	43,211	43,819	40,497	47,794	31,136	34,647	36,562	42,138	44,314	47,410	39,268	42,671	41,803	35,664
Long-Term Debt	60,565	61,641	57,409	57,502	57,639	57,405	58,002	57,506	61,307	61,538	61,048	61,356	31,704	32,884	32,629	34,294	35,656	36,195	36,250	35,354
Other Long-Term Liabilities	22,301	22,758	21,630	21,855	23,300	24,499	25,705	26,894	26,732	27,880	25,632	24,871	26,115	26,265	25,516	26,116	26,231	25,147	25,168	28,587
Total Long-Term Liabilities	82,866	84,399	79,039	79,357	80,939	81,904	83,707	84,400	88,039	89,418	86,680	86,227	57,819	59,149	58,145	60,410	61,887	61,342	61,418	63,941
Total Liabilities	117,214	121,383	115,635	117,083	117,391	124,899	126,918	128,218	128,537	137,213	117,817	120,875	94,381	101,288	102,459	107,821	101,155	104,013	103,221	99,605
Common Stock	482	481	481	481	481	480	480	480	480	478	478	478	478	476	476	476	476	473	473	472
Treasury Stock	-115,190	-115,015	-115,011	-115,010	-115,008	-114,763	-114,760	-114,757	-114,755	-114,487	-114,485	-114,482	-114,473	-113,969	-113,945	-113,939	-113,931	-111,361	-111,359	-111,356
Additional Paid-in Capital	94,773	94,469	94,248	94,053	93,856	93,603	93,477	93,197	92,997	92,631	92,496	92,329	92,153	91,802	91,359	91,183	90,844	90,591	89,973	89,336
Accumulated Other Comprehensive Income	-7,203	-8,069	-8,066	-8,438	-8,581	-7,842	-7,971	-7,816	-7,758	-7,961	-7,966	-8,102	-8,289	-8,304	-8,225	-7,119	-6,157	-5,897	-5,649	-4,758
Retained Earnings	117,238	114,610	121,150	117,609	119,590	116,725	121,059	116,596	121,318	118,353	126,411	128,796	131,102	125,656	122,967	116,608	111,193	103,394	102,252	96,346
Total Common Shareholders' Equity	90,101	86,476	92,801	88,695	90,338	88,203	92,286	87,700	92,282	89,014	96,934	99,019	100,970	95,661	92,631	87,208	82,424	77,201	75,691	70,042
Minority Interest	303	299	295	317	299	294	272	275	276	274	270	274	266	256	259	261	261	262	275	273
Shareholders' Equity	90,404	86,775	93,096	89,012	90,637	88,497	92,558	87,975	92,558	89,288	97,204	99,293	101,236	95,916	92,891	87,469	82,685	77,462	75,967	70,315
Total Liabilities & Equity	207,618	208,160	208,731	206,095	208,028	213,396	219,476	216,193	221,095	226,501	215,021	220,168	195,617	197,205	195,350	195,290	183,841	181,476	179,188	169,920
Total Debt	64,455	64,795	61,712	61,797	62,109	64,351	67,701	69,450	69,539	71,888	63,596	65,341	35,892	35,829	36,669	40,284	36,301	38,436	39,879	39,242
Net Cash (Debt)	-51,380	-51,199	-46,728	-48,548	-44,792	-43,874	-57,749	-62,350	-57,611	-59,198	-19,415	-20,556	-15,920	-13,097	-546	-6,980	-12,404	-7,367	-10,183	-17,542
Net Cash Per Share	-8.96	-8.95	-8.18	-8.51	-7.84	-7.69	-10.12	-10.95	-10.11	-10.48	-3.44	-3.60	-2.78	-2.28	-0.10	-1.22	-2.15	-1.28	-1.78	-3.09
Book Value	90,101	86,476	92,801	88,695	90,338	88,203	92,286	87,700	92,282	89,014	96,934	99,019	100,970	95,661	92,631	87,208	82,424	77,201	75,691	70,042
Book Value Per Share	15.72	15.11	16.24	15.54	15.82	15.47	16.18	15.40	16.20	15.76	17.17	17.33	17.63	16.66	16.20	15.27	14.31	13.38	13.22	12.34
Tangible Book Value	-33,867	-38,519	-27,624	-33,004	-32,082	-35,735	-36,270	-41,985	-39,844	-43,669	5,183	6,041	7,492	916	15,039	8,252	2,397	2,847	-104	-7,148
Tangible Book Value Per Share	-5.91	-6.73	-4.83	-5.78	-5.62	-6.27	-6.36	-7.37	-6.99	-7.73	0.92	1.06	1.31	0.16	2.63	1.44	0.42	0.49	-0.02	-1.26

SEC Filings: 10-K · 10-Q